|
Written by SOURCE S1 Pharmaceuticals, Inc.
|
|
Tuesday, 24 April 2012 |
|
S1 Pharmaceuticals, Inc., a developer of therapeutics for disorders of women's sexual health, announced today an executive management addition and Scientific Advisory Board appointment that strengthen and expand the Company's leadership: |
|
Read more...
|